These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 10100218)
1. (+)-p-([18F]fluorobenzyl)spirotrozamicol [(+)-[18F]spiro-FBT]: synthesis and biological evaluation of a high-affinity ligand for the vesicular acetylcholine transporter (VAChT). Efange SM; Nader MA; Ehrenkaufer RL; Khare AB; Smith CR; Morton TE; Mach RH Nucl Med Biol; 1999 Feb; 26(2):189-92. PubMed ID: 10100218 [TBL] [Abstract][Full Text] [Related]
2. Imaging of cholinergic terminals using the radiotracer [18F](+)-4-fluorobenzyltrozamicol: in vitro binding studies and positron emission tomography studies in nonhuman primates. Mach RH; Voytko ML; Ehrenkaufer RL; Nader MA; Tobin JR; Efange SM; Parsons SM; Gage HD; Smith CR; Morton TE Synapse; 1997 Apr; 25(4):368-80. PubMed ID: 9097396 [TBL] [Abstract][Full Text] [Related]
3. [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses. Mulholland GK; Wieland DM; Kilbourn MR; Frey KA; Sherman PS; Carey JE; Kuhl DE Synapse; 1998 Nov; 30(3):263-74. PubMed ID: 9776130 [TBL] [Abstract][Full Text] [Related]
4. Piperazine analog of vesamicol: in vitro and in vivo characterization for vesicular acetylcholine transporter. Bando K; Naganuma T; Taguchi K; Ginoza Y; Tanaka Y; Koike K; Takatoku K Synapse; 2000 Oct; 38(1):27-37. PubMed ID: 10941138 [TBL] [Abstract][Full Text] [Related]
5. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles. Weihe E; Tao-Cheng JH; Schäfer MK; Erickson JD; Eiden LE Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3547-52. PubMed ID: 8622973 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological characterization of stable and radioiodinated (+/-)-trans-2-hydroxy-3-P[4-(3-iodophenyl)piperidyl]-1,2,3,4-tetrahydronaphthalene (3'-IBVM). Efange SM; von Hohenberg K ; Khare AB; Tu Z; Mach RH; Parsons SM Nucl Med Biol; 2000 Nov; 27(8):749-55. PubMed ID: 11150707 [TBL] [Abstract][Full Text] [Related]
8. A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter. Sorger D; Scheunemann M; Grossmann U; Fischer S; Vercouille J; Hiller A; Wenzel B; Roghani A; Schliebs R; Brust P; Sabri O; Steinbach J Nucl Med Biol; 2008 Feb; 35(2):185-95. PubMed ID: 18312828 [TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography imaging of (2R,3R)-5-[(18)F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter. Kilbourn MR; Hockley B; Lee L; Sherman P; Quesada C; Frey KA; Koeppe RA Nucl Med Biol; 2009 Jul; 36(5):489-93. PubMed ID: 19520289 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter. Tu Z; Efange SM; Xu J; Li S; Jones LA; Parsons SM; Mach RH J Med Chem; 2009 Mar; 52(5):1358-69. PubMed ID: 19203271 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of the vesamicol analogue (+)-[(125)I]MIBT in primate brain. Staley JK; Mash DC; Parsons SM; Khare AB; Efange SM Eur J Pharmacol; 1997 Nov; 338(2):159-69. PubMed ID: 9455998 [TBL] [Abstract][Full Text] [Related]
12. Vesicular acetylcholine transporter in the rat cochlear nucleus: an immunohistochemical study. Yao W; Godfrey DA J Histochem Cytochem; 1999 Jan; 47(1):83-90. PubMed ID: 9857215 [TBL] [Abstract][Full Text] [Related]
13. Photoaffinity labeling of vesicular acetylcholine transporter from electric organ of Torpedo. Parsons SM; Rogers GA; Gracz LM Methods Enzymol; 1998; 296():99-116. PubMed ID: 9779443 [No Abstract] [Full Text] [Related]
15. Synthesis and evaluation of a new vesamicol analog o-[(11)C]methyl-trans-decalinvesamicol as a PET ligand for the vesicular acetylcholine transporter. Kitamura Y; Kozaka T; Miwa D; Uno I; Azim MA; Ogawa K; Taki J; Kinuya S; Shiba K Ann Nucl Med; 2016 Feb; 30(2):122-9. PubMed ID: 26608176 [TBL] [Abstract][Full Text] [Related]
16. Dissociation of the vesicular acetylcholine transporter domains important for high-affinity transport recognition, binding of vesamicol and targeting to synaptic vesicles. Varoqui H; Erickson JD J Physiol Paris; 1998 Apr; 92(2):141-4. PubMed ID: 9782458 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising σ1 receptor imaging agent. Chen YY; Wang X; Zhang JM; Deuther-Conrad W; Zhang XJ; Huang Y; Li Y; Ye JJ; Cui MC; Steinbach J; Brust P; Liu BL; Jia HM Bioorg Med Chem; 2014 Oct; 22(19):5270-8. PubMed ID: 25189691 [TBL] [Abstract][Full Text] [Related]
18. Radiosynthesis and evaluation of a fluorine-18 labeled radioligand targeting vesicular acetylcholine transporter. Yue X; Luo Z; Liu H; Kaneshige K; Parsons SM; Perlmutter JS; Tu Z Bioorg Med Chem Lett; 2018 Nov; 28(21):3425-3430. PubMed ID: 30274694 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel 4- and 5-substituted benzyl ether derivatives of vesamicol and in vitro evaluation of their binding properties to the vesicular acetylcholine transporter site. Scheunemann M; Sorger D; Wenzel B; Heinitz K; Schliebs R; Klingner M; Sabri O; Steinbach J Bioorg Med Chem; 2004 Mar; 12(6):1459-65. PubMed ID: 15018919 [TBL] [Abstract][Full Text] [Related]
20. Analysis of uptake and release of newly synthesized acetylcholine in PC12 cells overexpressing the rat vesicular acetylcholine transporter (VAChT). Roghani A; Carroll PT Brain Res Mol Brain Res; 2002 Apr; 100(1-2):21-30. PubMed ID: 12008018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]